In addition, depletion of TFEB reduces proliferation of pancreatic and prostate cancer cells (Blessing et al., 2017; Perera et al., 2015), further suggesting that these transcription factors function as oncogenes. The gene discussed is TFEB; the disease is prostate cancer.